season influenza virus infect caps under thousand death annual viral mutant rail threat novel tandem strain antivirus drug exhibit limit efficacy unless admins early may induce resist thu target host response directly propos therapeutic strategy ad potent benefit elicit sever complex respiratory failure due develop lung microvascular leak act injury hypothesis enhance endothelial barrier inter could improv outcome demons tieagonist tetramer peptide vasculotid improv survive marin model even late hour infect observe use three strain two mouse effect require tie indeed replica impair neutrophil recruit administer drug decrease edema artery hypoxia apoptosis importantly inexpens product chemin stable unreal ligand metres practice therapy 